GPT and metabolic dysfunction-associated steatotic liver disease: Model 4, following adjustment for age, gender,BMI, history of MS, γ-GT, ALT, and HsCRP (p < 0.05 for all covariates),selected by stepwise regression, showed that serum amylase levels were independentfactors predicting advanced fibrosis (FIB-4 ≥ 1.3) in NAFLD participants (OR:1.840, 95% CI: 1.117-3.030, p = 0.017).